1. Home
  2. SGHT vs LSE Comparison

SGHT vs LSE Comparison

Compare SGHT & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • LSE
  • Stock Information
  • Founded
  • SGHT 2011
  • LSE 2007
  • Country
  • SGHT United States
  • LSE China
  • Employees
  • SGHT N/A
  • LSE N/A
  • Industry
  • SGHT Medical Specialities
  • LSE Metal Fabrications
  • Sector
  • SGHT Health Care
  • LSE Industrials
  • Exchange
  • SGHT Nasdaq
  • LSE Nasdaq
  • Market Cap
  • SGHT 140.1M
  • LSE 115.9M
  • IPO Year
  • SGHT 2021
  • LSE 2024
  • Fundamental
  • Price
  • SGHT $2.25
  • LSE $5.42
  • Analyst Decision
  • SGHT Buy
  • LSE
  • Analyst Count
  • SGHT 7
  • LSE 0
  • Target Price
  • SGHT $3.83
  • LSE N/A
  • AVG Volume (30 Days)
  • SGHT 270.5K
  • LSE 859.0K
  • Earning Date
  • SGHT 03-05-2025
  • LSE 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • LSE N/A
  • EPS Growth
  • SGHT N/A
  • LSE N/A
  • EPS
  • SGHT N/A
  • LSE 0.52
  • Revenue
  • SGHT $79,866,000.00
  • LSE $69,073,374.00
  • Revenue This Year
  • SGHT $3.09
  • LSE N/A
  • Revenue Next Year
  • SGHT $13.61
  • LSE N/A
  • P/E Ratio
  • SGHT N/A
  • LSE $11.39
  • Revenue Growth
  • SGHT N/A
  • LSE N/A
  • 52 Week Low
  • SGHT $2.17
  • LSE $3.76
  • 52 Week High
  • SGHT $8.45
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 37.59
  • LSE N/A
  • Support Level
  • SGHT $2.64
  • LSE N/A
  • Resistance Level
  • SGHT $3.13
  • LSE N/A
  • Average True Range (ATR)
  • SGHT 0.22
  • LSE 0.00
  • MACD
  • SGHT -0.05
  • LSE 0.00
  • Stochastic Oscillator
  • SGHT 6.38
  • LSE 0.00

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe and cost-effective energy solutions. The company's businesses segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment.

Share on Social Networks: